Compugen Valuation
| CGEN Stock | ILA 740.00 4.00 0.54% |
At this time, the firm appears to be overvalued. Compugen shows a prevailing Real Value of 668.43 per share. The current price of the firm is 740.0. Our model approximates the value of Compugen from analyzing the firm fundamentals such as Current Valuation of 12.53 M, return on equity of -0.44, and Shares Owned By Insiders of 5.50 % as well as examining its technical indicators and probability of bankruptcy. In general, most investors favor taking in undervalued instruments and trading overvalued instruments since, at some point, asset prices and their ongoing real values will blend.
Overvalued
Today
Please note that Compugen's price fluctuation is very steady at this time. Calculation of the real value of Compugen is based on 3 months time horizon. Increasing Compugen's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Compugen is useful when determining the fair value of the Compugen stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Compugen. Since Compugen is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Compugen Stock. However, Compugen's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 740.0 | Real 668.43 | Hype 740.0 | Naive 683.34 |
The real value of Compugen Stock, also known as its intrinsic value, is the underlying worth of Compugen Company, which is reflected in its stock price. It is based on Compugen's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Compugen's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Compugen's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Compugen helps investors to forecast how Compugen stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Compugen more accurately as focusing exclusively on Compugen's fundamentals will not take into account other important factors: Compugen Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Compugen's current stock value. Our valuation model uses many indicators to compare Compugen value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Compugen competition to find correlations between indicators driving Compugen's intrinsic value. More Info.Compugen is number one stock in price to book category among related companies. It is number one stock in price to sales category among related companies fabricating about 41.64 of Price To Sales per Price To Book. Comparative valuation analysis is a catch-all model that can be used if you cannot value Compugen by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Compugen's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Compugen's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Compugen's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Compugen and how it compares across the competition.
About Compugen Valuation
The stock valuation mechanism determines the current worth of Compugen on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Compugen. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Compugen based exclusively on its fundamental and basic technical indicators. By analyzing Compugen's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Compugen's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Compugen. We calculate exposure to Compugen's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Compugen's related companies.Compugen Ltd., a clinical-stage therapeutic discovery and development company, engages in the research, development, and commercialization of therapeutic and product candidates in Israel, the United States, and Europe. Compugen Ltd. was incorporated in 1993 and is headquartered in Holon, Israel. COMPUGEN operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 68 people.
8 Steps to conduct Compugen's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Compugen's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Compugen's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Compugen's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Compugen's revenue streams: Identify Compugen's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Compugen's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Compugen's growth potential: Evaluate Compugen's management, business model, and growth potential.
- Determine Compugen's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Compugen's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Compugen. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Compugen Stock refer to our How to Trade Compugen Stock guide.You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Complementary Tools for Compugen Stock analysis
When running Compugen's price analysis, check to measure Compugen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Compugen is operating at the current time. Most of Compugen's value examination focuses on studying past and present price action to predict the probability of Compugen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Compugen's price. Additionally, you may evaluate how the addition of Compugen to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |